Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene

Nature Genetics

Volumn 15, Issue 3, 1997, Pages 303-306

  Yergeau, Donald A ^a   Hetherington, Christopher J ^a   Wang, Qing ^b   Zhang, Pu ^a   Sharpe, Arlene H ^c   Binder, Michael ^b   Marín Padilla, Miguel ^b   Tenen, Daniel G ^a   Speck, Nancy A ^b   Zhang, Dong Er ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 21; CHROMOSOME 8; CHROMOSOME TRANSLOCATION 8; EMBRYO; EMBRYO DEATH; GENE TARGETING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LETHALITY; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CHIMERA; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; CLONING, MOLECULAR; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CROSSES, GENETIC; DNA-BINDING PROTEINS; EXONS; FEMALE; FETAL DEATH; HEMATOPOIESIS; HETEROZYGOTE DETECTION; HUMANS; LEUKEMIA, MYELOID; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; YOLK SAC;

ANIMALIA;

EID: 0031025416     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0397-303     Document Type: Article

References (30)

1. Rowley, J.D. Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. Cancer Res. 44, 3159-3168 (1984).
2. Bitter, M.A. et al. Associations between morphology, karyotype, and clinical features in myeloid leukemias. Hum. Pathol. 18, 211-225 (1987).
3. Miyoshi, H. et al. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88, 10431-10434 (1991).
4. Erickson, P. et al. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80, 1825-1831 (1992).
5. Nisson, P.E., Watkins, P.C. & Sacchi, N. Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells. Cancer Genet. Cytogenet. 63, 81-88 (1992).
6. Wang, Q. et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoesis. Proc. Natl. Acad. Sci. USA 93, 3444-3449 (1996).
7. Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G. & Downing, J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330 (1996).
8. Wang, Q. et al. The core-binding factor (CBF) subunit is essential for CBF12 (AML1) function in vivo. Cell 87, 697-708 (1996).
9. Miyoshi, H. et al. The t(8-21) Translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 12, 2715-2721 (1993).
10. Capecchi, M.R. Altering the genome by homologous recombination. Science 244, 1288-1292 (1989).
11. Williams, B.O. et al. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13, 4251-4259 (1994).
12. Erickson, P.F. et al. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: Implications for t(8;21) leukemogenesis and monitoring residual disease. Blood 88, 1813-1823 (1996).
13. Meyers, S., Lenny, N., Sun, W. & Hiebert, S.W. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene 13, 303-312 (1996).
14. Gottschalk, L.R. & Leiden, J.M. Identification and functional characterization of the human T-cell receptor beta gene transcriptional enhancer: common nuclear proteins interact with the transcriptional regulatory elements of the T-cell receptor alpha and beta genes. Mol. Cell. Biol. 10, 5486-5495 (1990).
15. Frank, R. et al. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene 11, 2667-2674 (1995).
16. Hsiang, Y.H., Spencer, D., Wang, S., Speck, N.A. & Raulet, D.H. The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-gamma and -delta gene expression. J Immunol. 150, 3905-3916 (1993).
17. Cameron, S., Taylor, D.S., Tepas, E.C., Speck, N.A. & Mathey-Prevot, B. Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo footprinting. Blood 83, 2851-2859 (1994).
18. Suzow, J. & Friedman, A.D. The murine myeloperoxidase promoter contains several functional elements, one of which binds a cell type-restricted transcription factor, myeloid nuclear factor 1 (MyNF1). Mol. Cell. Biol. 13, 2141-2151 (1993).
19. Nuchprayoon, I. et al. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2beta/CBFbeta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol. Cell. Biol. 14, 5558-5568 (1994).
20. Zhang, D.E. et al. Identification of a region which directs monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol. Cell. Biol. 14, 8085-8095 (1994).
21. Wotton, D., Ghysdael, J., Wang, S., Speck, N.A. & Owen, M.J. Cooperative binding of Ets-1 and core binding factor to DNA. Mol. Cell. Biol. 14, 840-850 (1994).
22. Giese, K., Kingsley, C., Kirshner, J.R. & Grosschedl, R. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9, 995-1008 (1995).
23. Armesilla, A.L., Calvo, D. & Vega, M.A. Structural and functional characterization of the Human CD36 gene promoter. J. Biol. Chem. 271, 7781-7787 (1996).
24. Meyers, S., Lenny, N. & Hiebert, S.W. The t(8:21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol. Cell. Biol. 15, 1974-1982 (1995).
25. Rhoades, K.L. et al. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Proc. Natl. Acad. Sci. USA 93, 11895-11900 (1996).
26. Haas, J.G. et al. Constitutive monocyte-restricted activity of NF-M, a nuclear factor that binds to a C/EBP motif. J. Immunol. 149, 237-243 (1992).
27. Liu, P. et al. Fusion between transcription factor CBFß/PEBP2ß and a myosin heavy chain in acute myeloid leukemia. Science 261, 1041-1044 (1993).
28. Castilla, L.H. et al. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 87, 687-696 (1996).
29. Li, E., Bestor, T.H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926 (1992).
30. Tsai, F.Y. et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371, 221-226 (1994).